Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FTO | Q9C0B1 | 1/20 | 0.46 |
| ▸ | ACE | P12821 | 3/20 | 0.43 |
| ▸ | PPARA | Q07869 | 5/20 | 0.41 |
| ▸ | PPARG | P37231 | 3/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6365995 | 1.00 | FTO (0.46) | FTOACEPPARAPPARGELANE | |
| SCHEMBL6373029 | 0.90 | FTO (0.43) | FTOACEPPARAPPARGELANE | |
| SCHEMBL6373032 | 0.90 | FTO (0.43) | FTOACEPPARAPPARGELANE | |
| SCHEMBL6365249 | 0.88 | ACE (0.48) | FTOACEPPARAPPARGELANE | |
| SCHEMBL6365244 | 0.88 | ACE (0.48) | FTOACEPPARAPPARGELANE | |
| SCHEMBL6366531 | 0.86 | MCL1 (0.40) | PPARAPPARGPTPN1CDK2MCHR1 | |
| SCHEMBL6366525 | 0.86 | MCL1 (0.40) | PPARAPPARGPTPN1CDK2MCHR1 | |
| SCHEMBL6365690 | 0.86 | ACE (0.43) | FTOACEPPARAPPARGELANE | |
| SCHEMBL6365695 | 0.86 | ACE (0.43) | FTOACEPPARAPPARGELANE | |
| SCHEMBL6372203 | 0.86 | ACE (0.46) | FTOACEPPARAPPARGELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050272784-A1 | Inhibitors of bacterial Type III protein secretion systems | LI XIAOBING | 2005-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272784-A1 | Inhibitors of bacterial Type III protein secretion systems | GBA3, PSMB3, SEC61B | FTO 4883/4885ACE 1126/4885PPARA 4250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.